The document discusses HIV/AIDS research from 1993, including questions around vaccines, viral replication mechanisms, potential drug targets, and the limited drug treatments available at the time. It notes that by 1993, only nucleoside reverse transcriptase inhibitors like AZT had been developed to treat HIV, and that protease inhibitors and non-nucleoside reverse transcriptase inhibitors were just beginning to be studied.